drugset / Trial / NCT01114308

A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction

NCT01114308

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Probuphine (buprenorphine implant) is an implant placed just below the skin containing buprenorphine (BPN). BPN is an approved treatment for opioid dependence. This study will confirm the efficacy of Probuphine vs. placebo and compare Probuphine treatment verses treatment with sublingual buprenorphine in the treatment of patients with opioid dependence.

Timeline

Start
2010-04
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 12 mg Subcutaneous
Subject Buprenorphine Other / unclassified 16 mg Subcutaneous
Subject Buprenorphine Other / unclassified 80 mg Subcutaneous

Indications